XML 19 R9.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
OPERATING ACTIVITIES:    
Net income (loss) $ 538 $ 539
Adjustments to reconcile to net cash provided (used) by operating activities:    
Depreciation and amortization 840 865
Provision (benefit) for deferred income taxes 182 142
Equity (earnings) losses (167) (174)
Distributions from unconsolidated affiliates 327 316
Net (gain) loss on disposition of equity-method investments (Note 5) (122) 0
Impairment of equity-method investments (Note 5) 72 0
(Gain) loss on deconsolidation of businesses (Note 5) 2 (62)
Tangible Asset Impairment Charges 76 66
Amortization of stock-based awards 30 30
Cash provided (used) by changes in current assets and liabilities:    
Accounts and notes receivable 149 121
Inventories 4 (33)
Other current assets and deferred charges (16) (63)
Accounts payable (98) (70)
Accrued liabilities 70 (7)
Other, including changes in noncurrent assets and liabilities (43) (85)
Net cash provided (used) by operating activities 1,844 1,585
FINANCING ACTIVITIES:    
Proceeds from (payments of) commercial paper – net (4) 0
Proceeds from long-term debt 720 2,179
Payments of long-term debt (868) (1,761)
Proceeds from issuance of common stock 6 11
Proceeds from sale of partial interest in consolidated subsidiary (Note 2) 1,330 0
Common dividends paid (921) (563)
Dividends and distributions paid to noncontrolling interests (68) (356)
Contributions from noncontrolling interests 32 11
Payments for debt issuance costs 0 (18)
Other – net (9) (43)
Net cash provided (used) by financing activities 218 (540)
INVESTING ACTIVITIES:    
Capital expenditures (1) (919) (1,890)
Dispositions – net (15) 3
Contributions in aid of construction 18 339
Purchases of businesses, net of cash acquired (Note 2) (727) 0
Proceeds from dispositions of equity-method investments (Note 5) 485 0
Purchases of and contributions to equity-method investments (242) (91)
Other – net (24) (30)
Net cash provided (used) by investing activities (1,424) (1,669)
Increase (decrease) in cash and cash equivalents 638 (624)
Cash and cash equivalents at beginning of year 168 899
Cash and cash equivalents at end of period 806 275
(1) Increases to property, plant, and equipment (977) (1,864)
Changes in related accounts payable and accrued liabilities 58 (26)
Capital expenditures (1) $ (919) $ (1,890)